The Latest in Using Tech To Improve Drug Trials
INTERVIEW ON THE PRICE OF BUSINESS SHOW, MEDIA PARTNER OF THIS SITE.
Recently Kevin Price, Host of the nationally syndicated Price of Business Show, interviewed Dr. Shakthi Kumar.
On a recent Price of Business show, Host Kevin Price interviewed Dr. Shakthi Kumar, Chief Strategy and Business Officer, EDETEK.
EDETEK Previews 2025 Clinical Development Market – Sets Stage for Attendance at JPM Healthcare Conference
Dr. Shakthi Kumar, Chief Strategy and Business Officer, EDETEK appeared on Price of Business to discuss the exciting and growing sector of clinical data management. Dr. Kumar forecasts continued growth in Pharmaceutical and biotech R&D, as well as increasing digitization and complexity of clinical trials. He reports there will be an industry shift towards centralized technology and data driven clinical informatics ecosystems as companies look to enhance operational efficiencies and adhere to regulatory compliance.
Dr. Kumar updated POB listeners about EDETEK — a Life Sciences R&D company that provides specialized clinical development software and services to support the needs of pharmaceutical, biotech, and medical devices industries.
He outlined its two flagship software platforms: eClinical and CONFORM™. CONFORM is a powerful software platform that increases speed and quality of clinical trial execution. CONFORM™ automates the drug development processes while shortening cycle times, reducing burden on study stakeholders, including sites and patients, and ultimately reducing costs. CONFORM supports the integration of data from any clinical source in near real-time. It enables review capabilities for clinical data collected from all sources and integrates the data into its final target environment.
EDETEK has been steadily investing and growing its capabilities in software platforms and services. EDETEK is developing a comprehensive “R&D Cloud” software ecosystem that pharma clients can adopt and incrementally layer the capabilities. Dr. Kumar was also excited that EDETEK recently launched CONFORM ONCO+ — a therapeutic area-specific accelerator designed for oncology protocols inclusive of Phase 1, 2, 3, or 4. Designed to significantly improve cancer clinical trial and data management, this accelerator significantly enhances performance and efficiency by leveraging the latest advancements in Artificial Intelligence (AI)-driven analytics and advanced data management techniques.
Finally, Dr. Kumar announced that EDETEK will be attending the JP Morgan Healthcare week conference. The largest global healthcare investor event, #JPMWeek brings together pharma, biotechnology and technology companies with the investment community and facilitates networking and deal-making. EDETEK’s goal at JPM Week is to engage in insightful discussions with its peers on key priorities and developments. In addition, this event provides attendees an opportunity to engage with the investment community as well.
Learn more at www.EDETEK.com.
LinkedIn: https://www.linkedin.com/company/edetek/posts/?feedView=all
The Price of Business is one of the longest running shows of its kind in the country and is in markets coast to coast. The Host, Kevin Price, is a multi-award winning author, broadcast journalist, and syndicated columnist. Learn more about the show and its digital partners at www.PriceofBusiness.com (scroll down to the bottom of the page).
For more great lifestyle content see here.
About Author
